BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Leukocyte
,
DNA fingerprint
,
Phenobarbital
,
rs7903146
,
FABP1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
5 nucleotidase
Summary
General Info
Curated Studies
Most Correlated Studies
Pancreatic cancer PANC-1 cells with CD73 siRNA knockdown
Neural stem CTX0E16 cells with siRNA knockdown of the schizophrenia susceptibility gene NT5C2
Explore Curated Studies Results
Literature
Most Relevant Literature
Lack of ecto-5'-nucleotidase (CD73) promotes arteriogenesis.
Identification of small molecule sulfonic acids as ecto-5'-Nucleotidase inhibitors.
Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.
Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis.
Functional Characterization of ent-Copalyl Diphosphate Synthase and Kaurene Synthase Genes from Coff…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucle…
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
Effect of Oral Zinc Sulfate Supplementation on Enzymes of Urate Pathway
Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ